The Activation of the JAK2/STAT5 Pathway Is Commonly Involved in Signaling through the Human IL-5 Receptor

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 24-27

  Ogata, Norihisa ^a   Kikuchi, Yuji ^a   Kouro, Taku ^a   Tomonaga, Masao ^b   Takatsu, Kiyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Human; IL 5; JAK STAT pathway; Signal transduction

Indexed keywords

BUTYRIC ACID; COMPLEMENTARY DNA; INTERLEUKIN 5 RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR SUBUNIT; STAT1 PROTEIN; STAT5 PROTEIN; TYROSINE;

CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL LINE; DNA-BINDING PROTEINS; EOSINOPHILS; HUMANS; INTERLEUKIN-5; JANUS KINASE 2; MILK PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0030697889     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237712     Document Type: Article

References (12)

1. Koike M, Takatsu K: IL-5 and its receptor: Which role do they play in the immune response?. Int Arch Allergy Immunol 1994:104: 1-9.
2. van der Brüggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JAM, Lammcrs JWJ, Koenderman L: lnterleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Statla. Blood 1995;85:1442-1448.
3. Bates ME, Bcrtcs PJ, Bussue WW: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 1996:156:711-718.
4. Pazdrak K. Justement L. Alant R: Mechanism of inhibition of eosinophils activation by transforming growth factor-ß: Inhibition of lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J Immunol 1995;155:4454-4458.
5. Pazdrak K, Schreiber D, Forsythe P, Justement L, Alam R: The intercellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of lyn tyrosine kinase and the Ras-Raf-l-MEK Microtubulc-associatcd protein kinase pathway. J Exp Med 1995; 181: 1827-1834.
6. Sato S, Katagiri T, Takaki S, Kikuchi Y, Hito-shi Y, Yonehara S, Tsukada S, Kitamura D, Watanabe T, Witte O, Takatsu K: IL-5 receptor-mediated tyrosine phosphorylation of SH2/ SH3-containing protein and activation of Bruton’s tyrosine and Janus 2 kinases. J Exp Med 1994;180:2101-2111.
7. Kouro T, Kikuchi Y, Kanazawa H, Hirokawa K, Harada N, Shiiba M, Wakao H, Takaki S, Takatsu K: Critical proline residues of the cytoplasmic domain of the IL-5 receptor a-chain and its function in lL-5-mediated activation of JAK kinase and STATS. Int Immunol I996;8: 237-245.
8. Tomonaga M, Gasson JC, Quan SG, Golde DW: Establishment of eosinophilic sublincs from human promyelocytic leukemia (HL-60) cells: Demonstration of multipotentiality and single-lineage commitment of HL-60 stem cells. Blood 1986:67:1433-1441.
9. Wakao H, Harada N, Kitamura T, Mui ALF, Miyajima A: Interleukin-2 and erythropoietin activate STAT5/MGF via distinct pathway. EM BO J 1995;14:2527-2535.
10. Scoggan KA, Ford-Hutchinson AW, Nicholson DW Differential activation of lcukotricnc biosynthesis by granulocyte-macrophage colony-stimulating factor and interleukin-5 in an eosinophilic substrain of HL-60 cells. Blood 1995;86:3507-3516.
11. Taniguchi T: Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995;268:251-255.
12. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ: The role of shared receptor motifs and common Stal proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995:2:331-339.